Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/7180
Full metadata record
DC FieldValueLanguage
dc.contributor.authorParikh, Palak K.-
dc.contributor.authorGhate, Manjunath-
dc.contributor.authorPatel, Kinjal-
dc.date.accessioned2016-10-28T06:02:08Z-
dc.date.available2016-10-28T06:02:08Z-
dc.date.issued2015-
dc.identifier.urihttp://hdl.handle.net/123456789/7180-
dc.descriptionJournal of Pharmacy Research, 9(6);June 2015en_US
dc.publisherRELX India Pvt. Ltden_US
dc.relation.ispartofseriesIPFP0227;-
dc.title3D QSAR Studies on Substituted Arylaminopyrimidine Derivatives as Anaplastic Lymphoma Kinase (ALK) Inhibitorsen_US
dc.typeArticleen_US
Appears in Collections:Faculty Papers

Files in This Item:
File Description SizeFormat 
IPFP0227.pdfIPFP0227343.56 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.